[
  {
    "ts": null,
    "headline": "Gilead Sciences (GILD) Announces Marketing Authorization for Yeytuo from the European Commission",
    "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the top most undervalued low volatility stocks to buy now. On August 26, Gilead Sciences, Inc. (NASDAQ:GILD) announced that it attained marketing authorization for Yeytuo (lenacapavir) from the European Commission (EC). Yeytuo is the company’s twice-yearly injectable HIV-1 capsid inhibitor that is used as “pre-exposure prophylaxis (PrEP) to […]",
    "url": "https://finnhub.io/api/news?id=5374d01c369bc618cf063ec5022a3520bdf575318f330c5a378f2ee95629e8d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756617040,
      "headline": "Gilead Sciences (GILD) Announces Marketing Authorization for Yeytuo from the European Commission",
      "id": 136596297,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences, Inc. (NASDAQ:GILD) is one of the top most undervalued low volatility stocks to buy now. On August 26, Gilead Sciences, Inc. (NASDAQ:GILD) announced that it attained marketing authorization for Yeytuo (lenacapavir) from the European Commission (EC). Yeytuo is the company’s twice-yearly injectable HIV-1 capsid inhibitor that is used as “pre-exposure prophylaxis (PrEP) to […]",
      "url": "https://finnhub.io/api/news?id=5374d01c369bc618cf063ec5022a3520bdf575318f330c5a378f2ee95629e8d4"
    }
  }
]